Dimensional Fund Advisors
ANTX icon

Dimensional Fund Advisors’s AN2 Therapeutics ANTX Stock Holding History

Dimensional Fund Advisors’s Portfolio ANTX Stock Details ANTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$368K Buy
+76,045
New +$327K ﹤0.01% 2998
2024
Q3 		– Sell
-25,150
Closed -$54.1K – 3353
2024
Q2 		$54.1K Sell
25,150
-12,965
-34% -$30.9K ﹤0.01% 3306
2024
Q1 		$124K Buy
+38,115
New +$415K ﹤0.01% 3238

Other funds holding ANTX

VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Dimensional Fund Advisors's ANTX Position: Q2 2026 in Review

Dimensional Fund Advisors opened a new position in AN2 Therapeutics (ANTX) in Q2 2026: 76,045 shares worth $368K. The stake represents ﹤0.01% of the portfolio and ranks #2998 among its holdings. This is a return to the name: Dimensional Fund Advisors previously reported a position in ANTX as recently as Q2 2024.

Dimensional Fund Advisors first reported a position in ANTX in Q1 2024 and has held it in 3 quarters since. 66 funds tracked by Wall St. Rank hold ANTX as of Q2 2026.

  • Dimensional Fund Advisors held 76,045 shares of AN2 Therapeutics worth $368K as of Q2 2026.
  • AN2 Therapeutics was a new Dimensional Fund Advisors position in Q2 2026.
  • AN2 Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2998 holding.
  • Dimensional Fund Advisors first reported a position in AN2 Therapeutics in Q1 2024 and has held it in 3 quarters since.
  • 66 funds tracked by Wall St. Rank held AN2 Therapeutics as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.